Tecnologías de adherencia digital como método complementario al tratamiento directamente observado de tuberculosis

Marjorie Alexandra Ramos Chabla, María José Reyes Tinoco, Carina Alexandra Serpa Andrade

Resumen


La tuberculosis es una enfermedad infecto-contagiosa provocada por la bacteria Mycobacterium tuberculosis. El manejo de esta patología se efectúa mediante la Terapia de Observación Directa, el cual ha sido el método estándar, sin embargo, el margen de error de este método depende de factores del paciente y del proveedor. El Programa Mundial contra la Tuberculosis promulgado por la Organización Mundial de la Salud (2017) abarca las recomendaciones del uso de tecnologías como un soporte para ayudar en la administración del tratamiento y mejorar la adherencia. Entre Las Tecnologías de Adherencia Digital certificadas son: Servicio de Mensajes Cortos de Texto, Dispositivo de Monitoreo de Eventos para Soporte de Medicación, y Tratamiento Asistido por Video. El objetivo de este trabajo es establecer el uso de las Tecnologías de Adherencia Digital como métodos complementarios al Tratamiento de Observación Directa de la tuberculosis para el control de pacientes en la atención primaria de salud.


Palabras clave


Adherencia Terapéutica; Terapia por Observación Directa; Telemedicina; Tuberculosis.

Texto completo:

PDF HTML

Referencias


Organización Mundial de la Salud. Manual operativo de la OMS sobre la tuberculosis [Internet]. Organizaciòn mundial de la Salud. 2022. 118 p. Available from: https://iris.paho.org/bitstream/handle/10665.2/55927/9789275325377_spa.pdf?sequence=1&isAllowed=y

Alsayed SSR, Gunosewoyo H. Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets. Int J Mol Sci. 2023;24(6):5202.

World Health Organization. Annual Global Tuberculosis Report [Internet]. 2022. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022%0Ahttps://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022#:~:text=context of global...-,Download,-Read More%0Ahtt

Ministerio de Salud Pública del Ecuador. Boletín Anual Tuberculosis 2018 Introducción [Internet]. Vol. 2017. 2018. Available from: https://www.salud.gob.ec/wp-content/uploads/2019/03/informe_anual_TB_2018UV.pdf

Pezzella AT. History of Pulmonary Tuberculosis. Thorac Surg Clin [Internet]. 2019;29(1):1–17. Available from: https://doi.org/10.1016/j.thorsurg.2018.09.002

Musiimenta A, Tumuhimbise W, Mugaba AT, Muzoora C, Armstrong-Hough M, Bangsberg D, et al. Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study. J Clin Tuberc Other Mycobact Dis [Internet]. 2019;17:100119. Available from: https://doi.org/10.1016/j.jctube.2019.100119

Ridho A, Alfian SD, van Boven JFM, Levita J, Yalcin EA, Le L, et al. Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials. BMC Public Health. 2018;24(1):1–14.

Garfein RS, Doshi RP. Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support. J Clin Tuberc Other Mycobact Dis [Internet]. 2019;17:100098. Available from: https://doi.org/10.1016/j.jctube.2019.100098

Leddy AM, Jaganath D, Triasih R, Wobudeya E, Bellotti De Oliveira MC, Sheremeta Y, et al. Social Determinants of Adherence to Treatment for Tuberculosis Infection and Disease Among Children, Adolescents, and Young Adults: A Narrative Review. J Pediatric Infect Dis Soc. 2022;11(Suppl 3):S79–84.

Rao JS, Diwan V, Kumar AA, Varghese SS, Sharma U, Purohit M, et al. Acceptability of video observed treatment vs. directly observed treatment for tuberculosis: a comparative analysis between South and Central India. Wellcome Open Res. 2022;7:152.

Drug-resistant T. Directrices unificadas de la OMS sobre la tuberculosis. Módulo 4: Tratamiento. Tratamiento de la tuberculosis farmacorresistente. In: Directrices unificadas de la OMS sobre la tuberculosis Módulo 4: Tratamiento Tratamiento de la tuberculosis farmacorresistente. 2022.

Rodrigues R, Varghese SS, Mahrous M, Ananthaneni Kumar A, Ahmed MN, D’Souza G. Feasibility and acceptability pilot of video-based direct observed treatment (vDOT) for supporting antitubercular treatment in South India: a cohort study. BMJ Open [Internet]. 2023;13(5):e065878. Available from: http://www.ncbi.nlm.nih.gov/pubmed/37247959%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC10230861

Minnesota Department of Health. Video directly observed therapy. Vol. 48, Health. 2018.

World Health Organization. Handbook for the use of Digital Technologies to support Tuberculosis medication adherence [Internet]. 2017. 58 p. Available from: http://apps.who.int/iris/bitstream/10665/205222/1/WHO_HTM_TB_2015.21_eng.pdf?ua=1

Johnston JC, van der Kop ML, Smillie K, Ogilvie G, Marra F, Sadatsafavi M, et al. The effect of text messaging on latent tuberculosis treatment adherence: A randomised controlled trial. Eur Respir J [Internet]. 2018;51(2). Available from: http://dx.doi.org/10.1183/13993003.01488-2017

Fang XH, Guan SY, Tang L, Tao FB, Zou Z, Wang JX, et al. Effect of short message service on management of pulmonary tuberculosis patients in Anhui Province, China: A prospective, randomized, controlled study. Med Sci Monit. 2017;23:2465–9.

Bediang G, Stoll B, Elia N, Abena JL, Geissbuhler A. SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): A randomised controlled trial. BMC Public Health. 2018;18(1):1–14.

Mwansa-Kambafwile JRM, Chasela C, Levin J, Ismail N, Menezes C. Treatment initiation among tuberculosis patients: the role of short message service (SMS) technology and Ward-based outreach teams (WBOTs). BMC Public Health [Internet]. 2022;22(1):1–13. Available from: https://doi.org/10.1186/s12889-022-12736-6

Wagstaff A, van Doorslaer E, Burger R. SMS nudges as a tool to reduce tuberculosis treatment delay and pretreatment loss to follow-up. A randomized controlled trial. PLoS ONES. 2019;14(6):1–14.

Wang N, Shewade HD, Thekkur P, Huang F, Yuan Y, Wang X, et al. Electronic medication monitor for people with tuberculosis: Implementation experience from thirty counties in China. PLoS One [Internet]. 2020;15(4):1–14. Available from: http://dx.doi.org/10.1371/journal.pone.0232337

Thomas BE, Kumar JV, Periyasamy M, Khandewale AS, Mercy JH, Raj EM, et al. Acceptability of the medication event reminder monitor for promoting adherence to multidrug-resistant tuberculosis therapy in two indian cities: Qualitative study of patients and health care providers. J Med Internet Res. 2021;23(6):1–31.

Manyazewal T, Woldeamanuel Y, Getinet T, Hoover A, Bobosha K, Fuad O, et al. Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial. eClinicalMedicine [Internet]. 2023;56:101820. Available from: https://doi.org/10.1016/j.eclinm.2022.101820

Manyazewal T, Woldeamanuel Y, Fekadu A, Holland DP, Marconi VC. Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients with Tuberculosis: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2022;5(9):E2230509.

Manyazewal T, Woldeamanuel Y, Holland DP, Fekadu A, Marconi VC. Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial. BMC Med [Internet]. 2022;20(1):1–18. Available from: https://doi.org/10.1186/s12916-022-02521-y

Story A, Aldridge RW, Smith CM, Garber E, Hall J, Ferenando G, et al. Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial. Lancet [Internet]. 2019;393(10177):1216–24. Available from: http://dx.doi.org/10.1016/S0140-6736(18)32993-3

Burzynski J, Mangan JM, Lam CK, Macaraig M, Salerno MM, Decastro BR, et al. In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial. JAMA Netw Open. 2022;5(1):1–13.

Holzman SB, Zenilman A, Shah M. Advancing patient-centered care in tuberculosis management: A mixed-methods appraisal of video directly observed therapy. Vol. 5, Open Forum Infectious Diseases. 2018.

Macaraig M, Lobato MN, McGinnis Pilote K, Wegener D. A National Survey on the Use of Electronic Directly Observed Therapy for Treatment of Tuberculosis. J Public Heal Manag Pract. 2018;24(6):567–70.

Nguyen TA, Pham MT, Nguyen TL, Nguyen VN, Pham DC, Nguyen BH, et al. Video Directly Observed Therapy to support adherence with treatment for tuberculosis in Vietnam: A prospective cohort study. Int J Infect Dis [Internet]. 2017;65:85–9. Available from: http://dx.doi.org/10.1016/j.ijid.2017.09.029

Ravenscroft L, Kettle S, Persian R, Ruda S, Severin L, Doltu S, et al. Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova. Eur Respir J [Internet]. 2020 Aug 1;56(2):2000493. Available from: http://erj.ersjournals.com/content/56/2/2000493.abstract

Gokce Celik K, Bektas Murat Y. Comparison of In-Person vs. Video Directly Observed Therapy (VDOT) on Stigma Levels in Tuberculosis Patients. J Am Board Fam Med. 2022;35(5):951–60.

Fekadu G, Jiang X, Yao J, You JHS. Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during the COVID-19 pandemic in a high-income country. Int J Infect Dis [Internet]. 2021;113:271–8. Available from: https://doi.org/10.1016/j.ijid.2021.10.029




DOI: https://doi.org/10.23857/pc.v9i2.7478

Enlaces de Referencia

  • Por el momento, no existen enlaces de referencia
';

Bookmark and Share




Polo del Conocimiento              

Revista Científico-Académica Multidisciplinaria

ISSN: 2550-682X

Casa Editora del Polo                                                 

Manta - Ecuador       

Dirección: Ciudadela El Palmar, II Etapa,  Manta - Manabí - Ecuador.

Código Postal: 130801

Teléfonos: 056051775/0991871420

Email: polodelconocimientorevista@gmail.com / director@polodelconocimiento.com

URL: https://www.polodelconocimiento.com/